The company said three of the future U.S. sites will focus on manufacturing active pharmaceutical ingredients. The fourth location will focus on injectable therapies.
Lilly said the sites have not been chosen yet, but the new locations will create 3,000 high-skilled jobs and employ 10,000 construction workers over the next five years.
Lilly previously invested $23 billion from 2020 to 2024 for new manufacturing sites in Wisconsin and North Carolina and expansions in its home state of Indiana.
Read the article.
